Cardiovascular Diseases: From Molecular Pharmacology to by Y. Robert Li

By Y. Robert Li

Written in an obtainable variety and constant structure, the ebook covers either the basics and advances within the pharmacology of cardiovascular medicines, in addition to their built-in functions within the administration of person cardiovascular diseases.

•    Integrates basics and up to date advances relating to cardiovascular medications, mixing simple and medical sciences had to successfully comprehend and deal with cardiovascular diseases
•    Facilitates knowing of drug motion and mechanism by way of protecting body structure / pathophysiology and pharmacology
•    Includes guidance and algorithms for pharmacotherapeutic administration of cardiovascular diseases
•    Uses case shows and research inquiries to improve knowing of the material
•    Serves as a source for pharmaceutical and clinical scholars and researchers drawn to cardiovascular concerns

Show description

Read or Download Cardiovascular Diseases: From Molecular Pharmacology to Evidence-Based Therapeutics PDF

Best cardiology books

Cardiology Essentials in Clinical Practice

This e-book addresses the whole cardiological pathology, and accompanies the reader via each one major situation, from prevalence and severity, to mechanisms, medical and lab analysis, and as much as therapy and analysis. The presentation is stronger by way of a number of tables and figures, to higher illustrate the similarities and variations among the mentioned entities.

Handbook of Cardiovascular CT: Essentials for Clinical Practice

'Handbook of Cardiac CT' is a primer for the sensible functionality and interpretation of cardiovascular computed tomography. This guide serves as a spouse to the textbook: 'Cardiac CT Imaging: analysis of Cardiovascular Disease' and gives crucial concise and functional textual content precis of every subject, with extra tables, algorithms, protocols and key photographs for orientation to and familiarization with vital disorder tactics.

Vascular Surgery

Vascular surgical procedure is a vital reduction for applicants sitting surgical procedure examinations who desire a sensible knowing of vascular surgical procedure. Edited through popular vascular surgeons within the united states and united kingdom, the booklet tackles the epidemiology and etiology of atherosclerosis and the way to judge sufferers with vascular disorder.

Complications in Cardiothoracic Surgery: Avoidance and Treatment

Drs. Little and Merrill draw on their services ordinarily thoracic and cardiac surgical procedure to check tracheobronchial operations, lung quantity aid operations, lung transplantation, minimally invasive esophagectomy, pleural operations, revascularizations, myocardial operations, and aortic and nice vessel operations.

Extra resources for Cardiovascular Diseases: From Molecular Pharmacology to Evidence-Based Therapeutics

Example text

Individual, social, environmental, pol­ icies and intervention, and access to quality healthcare) in order to ensure the achievement of this ambitious goal [32, 33]. 5 million new cases diagnosed each year. Cardiovascular diseases (notably myocardial infarction and stroke) are the leading cause of death in the United States and the largest cause of lower life expectancy among blacks. Related medical costs and pro­ ductivity losses approach $450 billion annually, and infla­ tion‐adjusted direct medical costs are projected to triple over the next two decades if present trends continue.

10â•… The three levels of prevention of cardiovascular diseases Level of prevention Description Primary prevention Primary prevention aims to prevent the disease from occurring. Primary prevention reduces both the incidence and prevalence of a disease. Health promotion targeting on avoiding the risk factors of cardiovascular diseases is an example of primary prevention The goal of secondary prevention is to find and treat disease early. In many cases, the disease can be cured if detected early.

However, cardiovascular diseases are still the leading cause of death in the United States. 3). 5) possibly due to effective preven­ tion and better treatments for heart attacks, congestive heart failure, stroke, and other conditions, the cardiovascular dis­ ease prevalence and costs have been growing steadily and are projected to increase substantially in the future. 5% of the US population is projected to have some form of cardiovascular diseases. Between 2010 and 2030, real total direct medical costs of cardiovascular dis­ eases are projected to triple, from $273 billion to $818 billion.

Download PDF sample

Rated 4.30 of 5 – based on 15 votes